Loss of anterior chamber-associated immune deviation (ACAID) in aged retinal degeneration (rd) mice

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 13, 1999, Pages 3209-3214

  Welge Lüßen, Ulrich ^a   Wilsch, Caren ^a   Neuhardt, Thomas ^a   Streilein, J Wayne ^b   Lütjen Drecoll, Elke ^a,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ARTICLE; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA DEGENERATION;

AGING; ANIMALS; ANTERIOR CHAMBER; AQUEOUS HUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE DISEASES, HEREDITARY; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OVALBUMIN; RATS; RATS, MUTANT STRAINS; RETINAL DEGENERATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032700494     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Streilein JW. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye. Eye. 1995;9: 236-240.
2. Takeuchi M, Kosiewicz M, Alard P, Streilein JW. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation. Eur J Immunol. 1997;27:1648-1656.
3. Ferguson TA, Fletcher S, Herndon J, Griffith TS. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J Immunol. 1995;155:1746-1756.
4. Schreckenberger M, Eichhorn M, Gottanka J, Döbig C, Lütjen-Drecoll E. Altered proportions of RCS-rat eyes. Exp Eye Res. 1994; 59:409-416.
5. May CA, Horneber M, Lütjen-Drecoll E. Quantitative and morphological changes of the choroid vasculature in RCS rats and their congenic controls. Exp Eye Res. 1996;63:75-84.
6. Berger W, Meindl A, van de Pol TJR, et al. Isolation of a candidate gene for Norrie disease by positional cloning. Nat Genet. 1992;1:199-203.
7. Richter M, Gottanka J, May CA, Welge-Lüßen U, Berger W, Lütjen-Drecoll E. Morphological changes in the retinal vasculature of Norrie Disease-mice. Invest Ophthalmol Vis Sci. 1998;39:2450-2457.
8. La Vail MM. The retinal pigment epithelium in mice and rats with inherited retinal degeneration. In: Zinn KM, Marmor MF, eds. The Retinal Pigment Epithelium. Cambridge, UK: Harvard University Press; 1979:357-380.
9. Neuhardt T, May CA, Eichhorn M, Wilsch C, Lütjen-Drecoll E. Morphological changes of retinal pigment epithelium and choriocapillaris in rd-mice. Exp Eye Res. 1999;68:75-83.
10. Kosiewicz, MM, Okamoto S, Miki S, Ksander BR, Shimizu T, Streilein JW. Imposing deviant immunity on the presensitized state. J Immunol. 1994;153:2962-2973.
11. Tanihara H, Yoshida M, Matsumoto M, Yoshimura N. Identification of transforming growth factor-β expressed in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1993; 34:413-419.
12. Peress N, Perillo E. TGF and TGF-β3 immunoreactivity within the ciliary epithelium. Invest Ophthalmol Vis Sci. 1994;35:454-476.
13. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189-1192.